Status:
ACTIVE_NOT_RECRUITING
Eat, Move, Live Program for the Reduction of Cancer and Chronic Disease Risk in Underserved Communities
Lead Sponsor:
City of Hope Medical Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Diabetes Mellitus
Obesity-Related Malignant Neoplasm
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This clinical trial tests the Eat, Move, Live (EML) Program in reducing the risk of chronic diseases among underserved communities by improving healthy lifestyle practices, increasing physical activit...
Detailed Description
PRIMARY OBJECTIVES: I. To evaluate program by assessing in combination with standard of care metformin: Changes in participants' knowledge, attitudes, and behavior. II. To evaluate program by assess...
Eligibility Criteria
Inclusion
- Agrees to group consent at week 1
- Age over 18
- Able to speak and understand English and/or Spanish
Exclusion
- Don't agree to group consent at week 1
- Age younger than 18
- Not able to speak and understand English and/or Spanish
- Can't participate in physical activity
Key Trial Info
Start Date :
March 20 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 12 2026
Estimated Enrollment :
347 Patients enrolled
Trial Details
Trial ID
NCT05414396
Start Date
March 20 2018
End Date
October 12 2026
Last Update
December 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
City of Hope Medical Center
Duarte, California, United States, 91010